Literature DB >> 31981076

Use of a Porcine Model to Evaluate the Risks and Benefits of Vasopressors in Propranolol Poisoning.

Jon B Cole1,2, Justin N Corcoran3,4, Kristin M Engebretsen4, Samuel J Stellpflug3,4.   

Abstract

INTRODUCTION: Vasopressors are a commonly used treatment in beta-blocker poisoning despite evidence they may be ineffective or harmful. The primary objective of the present study is to use previously collected data from two prior studies (high-dose insulin (HDI) versus vasopressin + epinephrine and a placebo-controlled HDI study) to compare survival between vasopressin + epinephrine and placebo. Secondary outcomes included a comparison with HDI as well as comparisons with hemodynamic parameters, including mean arterial pressure (MAP), cardiac output (CO), heart rate (HR), and systemic vascular resistance (SVR).
METHODS: Cardiogenic shock was induced in healthy pigs with a bolus of 0.5 mg/kg of intravenous propranolol followed by an infusion of 0.25 mg/kg/minute until the point of toxicity, defined as (0.75 × initial HR × initial MAP), at which point the infusion was reduced to 0.125 mg/kg/minute for 240 (vasopressin + epinephrine or HDI) or 360 minutes (placebo) or until death.
RESULTS: Survival was significantly lower in pigs receiving vasopressin + epinephrine (0%, 0/5) than in pigs receiving placebo (50%, 2/4) (p < 0.01). Survival was significantly higher with HDI compared with both groups (100%, 5/5) (p < 0.01). All vasopressin + epinephrine pigs died within 100 minutes after reaching toxicity. Over the course of the resuscitation, we observed a statistically significant steady decrease in CO and HR in the vasopressin + epinephrine group compared with placebo (p < 0.01). In contrast, we observed a statistically significant change in MAP and SVR that followed a parabolic arc, with MAP and SVR rising significantly initially in the vasopressin + epinephrine group then rapidly falling until death (p < 0.01).
CONCLUSIONS: Mortality was higher with vasopressors compared with placebo in this porcine model of propranolol poisoning. Further studies are warranted to define the optimal timing and role of vasopressors in beta-blocker poisoning.

Entities:  

Keywords:  Beta-blockers; Overdose; Poisoning; Propranolol; Vasopressors

Mesh:

Substances:

Year:  2020        PMID: 31981076      PMCID: PMC7099112          DOI: 10.1007/s13181-020-00758-8

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  41 in total

1.  A comparison of combined amrinone and glucagon therapy to glucagon alone for cardiovascular depression associated with propranolol toxicity in a canine model.

Authors:  J N Love; J A Leasure; D J Mundt
Journal:  Am J Emerg Med       Date:  1993-07       Impact factor: 2.469

2.  Addition of phenylephrine to high-dose insulin in dihydropyridine overdose does not improve outcome.

Authors:  Kristin M Engebretsen; Matthew W Morgan; Samuel J Stellpflug; Jon B Cole; Christopher P Anderson; Joel S Holger
Journal:  Clin Toxicol (Phila)       Date:  2010-10       Impact factor: 4.467

3.  Levosimendan as a rescue drug in experimental propranolol-induced myocardial depression: a randomized study.

Authors:  Heli Leppikangas; Esko Ruokonen; Juha Rutanen; Vesa Kiviniemi; Leena Lindgren; Jouni Kurola
Journal:  Ann Emerg Med       Date:  2009-09-19       Impact factor: 5.721

4.  High dose insulin for beta-blocker and calcium channel-blocker poisoning.

Authors:  Jon B Cole; Ann M Arens; JoAn R Laes; Lauren R Klein; Stacey A Bangh; Travis D Olives
Journal:  Am J Emerg Med       Date:  2018-02-06       Impact factor: 2.469

5.  A comparison of vasopressin and glucagon in beta-blocker induced toxicity.

Authors:  Joel S Holger; Kristin M Engebretsen; Christopher L Obetz; Tanya L Kleven; Carson R Harris
Journal:  Clin Toxicol (Phila)       Date:  2006       Impact factor: 4.467

6.  Asystole immediately following intravenous fat emulsion for overdose.

Authors:  Jon B Cole; Samuel J Stellpflug; Kristin M Engebretsen
Journal:  J Med Toxicol       Date:  2014-09

Review 7.  Pathophysiology and management of self-poisoning with beta-blockers.

Authors:  P Taboulet; A Cariou; A Berdeaux; C Bismuth
Journal:  J Toxicol Clin Toxicol       Date:  1993

8.  Combined use of glucagon and milrinone may not be preferable for severe propranolol poisoning in the canine model.

Authors:  S Sato; M H Tsuji; N Okubo; C Nishimoto; H Naito
Journal:  J Toxicol Clin Toxicol       Date:  1995

9.  Milrinone versus glucagon: comparative hemodynamic effects in canine propranolol poisoning.

Authors:  S Sato; M H Tsuji; N Okubo; H Naito
Journal:  J Toxicol Clin Toxicol       Date:  1994

10.  High-dose insulin: a consecutive case series in toxin-induced cardiogenic shock.

Authors:  Joel S Holger; Samuel J Stellpflug; Jon B Cole; Carson R Harris; Kristin M Engebretsen
Journal:  Clin Toxicol (Phila)       Date:  2011-08-08       Impact factor: 4.467

View more
  2 in total

1.  Additional Considerations for Persistent Hyperinsulinemia.

Authors:  Paula Gawedzki; Frank P Paloucek
Journal:  J Med Toxicol       Date:  2021-02-19

2.  Hemodynamic Effects of Cardiovascular Medications in a Normovolemic and Hemorrhaged Yorkshire-cross Swine Model.

Authors:  Jacob H Cole; Scott B Hughey; Phillip G Geiger; Kamala J Rapp-Santos; Gregory J Booth
Journal:  Comp Med       Date:  2021-12-07       Impact factor: 1.565

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.